Low-Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease

被引:1
|
作者
Zuarth-Vazquez, Julia [1 ]
Moreno-Castaneda, Lidia [1 ]
Soriano-Marquez, Juan Pablo [2 ]
Velazquez-Aleman, Alain [3 ]
Ramos-Ostos, Martha Helena [4 ]
Uribe, Misael [2 ]
Lopez-Mendez, Ivan [5 ]
Juarez-Hernandez, Eva [3 ]
机构
[1] Med Clin & Fdn, Internal Med Dept, Mexico City 14050, Mexico
[2] Med Clin & Fdn, Gastroenterol & Obes Unit, Mexico City 14050, Mexico
[3] Med Clin & Fdn, Translat Res Unit, Mexico City 14050, Mexico
[4] Med Clin & Fdn, Integral Diag & Treatment Ctr, Mexico City 14050, Mexico
[5] Med Clin & Fdn, Hepatol & Transplants Unit, Mexico City 14050, Mexico
来源
LIFE-BASEL | 2023年 / 13卷 / 04期
关键词
thyroid function; steatosis; metabolic syndrome; controlled attenuation parameter; GLOBAL EPIDEMIOLOGY; RISK; TSH;
D O I
10.3390/life13041048
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The association of low-normal thyroid function (LNTF) with non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD) is controversial; thus, the aim of this study is to determine this association. Methods: NAFLD was evaluated by controlled attenuation parameter of transient elastography. Patients were classified by MAFLD criteria. LNTF was defined as TSH levels of 2.5 to 4.5 mIU/L and were divided into three different cut-off points (>4.5 to 5.0, >3.1, and >2.5 mIU/L). Associations between LNTF, NAFLD, and MAFLD were evaluated by univariate and multivariate logistic regression analyses. Results: A total of 3697 patients were included; 59% (n = 2179) were male, and median age and body mass index were 48 (43-55) years and 25.9 (23.6-28.5) kg/m(2), respectively, and 44% (n = 1632) were diagnosed with NAFLD. THS levels of 2.5 and 3.1 showed significant associations with the presence of NAFLD and MAFLD; however, LNTF did not show an independent association with the presence of NAFLD or MAFLD in multivariate analysis. According to different cut-off points, patients with LNTF presented similar risks for NAFLD as the general population. Conclusion: LNTF is not associated with NAFLD or MAFLD. Patients with high LNTF are equally at risk for NAFLD as the general population.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sohn, Won
    Kwon, Heon-Ju
    Chang, Yoosoo
    Ryu, Seungho
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : E1135 - E1148
  • [42] The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
    Hu, Yingying
    Zhou, Fan
    Lei, Fang
    Lin, Lijin
    Huang, Xuewei
    Sun, Tao
    Liu, Weifang
    Zhang, Xingyuan
    Cai, Jingjing
    She, Zhi-Gang
    Li, Hongliang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [43] Effects of weight loss on metabolic dysfunction-associated fatty liver disease in Japanese people: Non-alcoholic fatty liver disease in the Gifu area, longitudinal analysis study
    Hasegawa, Yuka
    Okada, Hiroshi
    Nakajima, Hanako
    Kitagawa, Nobuko
    Okamura, Takuro
    Majima, Saori
    Senmaru, Takafumi
    Ushigome, Emi
    Nakanishi, Naoko
    Nakahata, Yuki
    Obora, Akihiro
    Kojima, Takao
    Hamaguchi, Masahide
    Fukui, Michiaki
    HEPATOLOGY RESEARCH, 2024, 54 (04) : 336 - 346
  • [44] Overlapping group between non-alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
    Cheng, Yu-Ming
    Hsieh, Tsung-Han
    Wang, Chia-Chi
    Kao, Jia-Horng
    JGH OPEN, 2024, 8 (10):
  • [45] HYPOTHYROIDISM IS NOT ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Zuarth-Vazquez, Julia
    Soriano-Marquez, Juan P.
    Velazquez-Aleman, Alain
    Moreno-Castaneda, Lidia
    Lopez-Mendez, Ivan
    Ramos-Ostos, Martha Helena
    Uribe, Misael
    Juarez-Hernandez, Eva
    HEPATOLOGY, 2022, 76 : S850 - S851
  • [46] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Ting-Yao Wang
    Rui-Fang Wang
    Zhi-Ying Bu
    Giovanni Targher
    Christopher D. Byrne
    Dan-Qin Sun
    Ming-Hua Zheng
    Nature Reviews Nephrology, 2022, 18 : 259 - 268
  • [47] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [48] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Alam, Shahinul
    Fahim, Shah Mohammad
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1203 - 1207
  • [49] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Shahinul Alam
    Shah Mohammad Fahim
    World Journal of Hepatology, 2021, 13 (10) : 1203 - 1207
  • [50] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268